Position
Parallel Advisors, LLC in Rhythm Pharmaceuticals, Inc.
Back to the book · All holders of RYTM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$502$107.04 → $86.96
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 25 | $2.68K | — | — | — | 0.0% |
| Q1 2026 | 25 | $2.17K | $86.96 | −$502 | $0 | 0.0% |